NASDAQ : AIDX
20/20 Biolabs, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 0.213 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.72M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
20/20 Biolabs, Inc. (AIDX) reported revenue of 2.04M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.04M | 2.05M | 1.75M | 1.42M | 11.06M | 9.62M |
| Cost of Revenue | 1.40M | 1.44M | 1.39M | 1.32M | 5.94M | 4.93M |
| Gross Profit | 643.09K | 604.54K | 360.31K | 109.14K | 5.12M | 4.69M |
| Selling, General & Admin | 4.37M | 3.34M | 4.76M | 5.06M | 3.32M | 2.56M |
| Research & Development | 672.73K | 592.57K | 1.26M | 1.41M | 120.04K | 193.37K |
| Operating Expenses | 5.04M | 3.94M | 6.02M | 6.47M | 3.44M | 2.75M |
| Operating Income | -4.40M | -3.33M | -5.66M | -6.36M | 1.68M | 1.94M |
| Interest Expense | -693.79K | -156.21K | -12.65K | -27.91K | -15.69K | -12.93K |
| Interest & Investment Income | 28.40K | 21.40K | 79.47K | 209.15K | 68.42K | 2.99K |
| Other Non Operating Income (Expenses) | -748.50K | -273.14K | 58.92K | -2.01K | 452.90K | 139.62K |
| EBT Excluding Unusual Items | -5.81M | -3.74M | -5.54M | -6.18M | 2.18M | 2.07M |
| Gain (Loss) on Sale of Assets | 2.37K | |||||
| Asset Writedown | -16.36K | -209.07K | ||||
| Pretax Income | -5.81M | -3.74M | -5.55M | -6.39M | 2.19M | 2.07M |
| Net Income | -5.81M | -3.74M | -5.55M | -6.39M | 2.19M | 2.07M |
| Net Income to Common | -7.12M | -3.74M | -5.55M | -6.39M | 2.19M | 2.07M |
| Shares Outstanding (Basic) | 7.13M | 4.93M | 4.80M | 4.77M | 4.76M | 4.73M |
| Shares Outstanding (Diluted) | 7.13M | 4.93M | 4.80M | 4.77M | 9.49M | 9.46M |
| EPS (Basic) | -1.00 | -0.76 | -1.16 | -1.34 | 0.46 | 0.44 |
| EPS (Diluted) | -1.00 | -0.76 | -1.16 | -1.34 | 0.23 | 0.22 |
| Free Cash Flow | -2.79M | -1.92M | -2.60M | -4.49M | 5.54M | -1.30M |
| Free Cash Flow Per Share | -0.39 | -0.39 | -0.54 | -0.94 | 0.58 | -0.14 |
| Gross Margin | 31.52% | 29.56% | 20.56% | 7.66% | 46.31% | 48.79% |
| Operating Margin | -215.70% | -162.87% | -323.06% | -446.64% | 15.18% | 20.18% |
| Profit Margin | -348.74% | -182.82% | -316.81% | -448.73% | 19.77% | 21.53% |
| Free Cash Flow Margin | -136.84% | -93.87% | -148.30% | -315.20% | 50.11% | -13.53% |
| EBITDA | -4.32M | -3.25M | -5.52M | -6.20M | 1.90M | 2.07M |
| EBITDA Margin | -211.83% | -158.68% | 17.18% | 21.47% | ||
| D&A For EBITDA | 78.94K | 85.76K | 138.53K | 165.20K | 220.84K | 123.66K |
| EBIT | -4.40M | -3.33M | -5.66M | -6.36M | 1.68M | 1.94M |
| EBIT Margin | -215.69% | -162.87% | 15.18% | 20.18% | ||
| Advertising Expenses | 167.47K | 533.94K | 780.13K | 358.34K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.55M | 1.03M | 1.78M | 4.09M | 8.81M | 3.35M |
| Cash & Short-Term Investments | 4.55M | 1.03M | 1.78M | 4.09M | 8.81M | 3.35M |
| Receivables | 291.49K | 199.95K | 135.27K | 68.83K | 764.92K | 4.22M |
| Inventory | 111.04K | 116.22K | 47.16K | 60.67K | 87.07K | 246.66K |
| Prepaid Expenses | 126.96K | 128.97K | 67.78K | 81.47K | 72.27K | 125.66K |
| Total Current Assets | 5.08M | 1.47M | 2.03M | 4.30M | 9.73M | 7.94M |
| Property, Plant & Equipment | 553.00K | 661.97K | 889.05K | 1.18M | 1.67M | 1.68M |
| Other Intangible Assets | 471.50K | 473.41K | 499.17K | 526.53K | 520.33K | 581.60K |
| Long-Term Accounts Receivable | 2.70K | 2.70K | ||||
| Long-Term Deferred Charges | 1.51M | 148.39K | ||||
| Other Long-Term Assets | 23.06K | 23.06K | 161.96K | 214.88K | 290.45K | 65.35K |
| Total Assets | 6.12M | 4.14M | 3.58M | 6.37M | 12.22M | 10.27M |
| Accounts Payable | 1.03M | 868.54K | 372.30K | 360.28K | 464.28K | 834.27K |
| Accrued Expenses | 864.66K | 785.78K | 346.62K | 232.69K | 649.79K | 1.12M |
| Current Portion of Long-Term Debt | 74.61K | |||||
| Current Portion of Leases | 192.73K | 175.95K | 165.70K | 163.79K | 199.87K | 145.03K |
| Current Unearned Revenue | 467.03K | 414.87K | 470.45K | 254.87K | 316.22K | 152.70K |
| Other Current Liabilities | 143.38K | |||||
| Total Current Liabilities | 2.55M | 2.46M | 1.36M | 1.01M | 1.63M | 2.25M |
| Long-Term Debt | 619.36K | 229.16K | 207.25K | |||
| Long-Term Leases | 379.72K | 488.73K | 673.85K | 839.55K | 1.00M | 1.13M |
| Long-Term Unearned Revenue | 32.92K | 41.82K | 50.00K | |||
| Other Long-Term Liabilities | 543.54K | |||||
| Total Liabilities | 2.96M | 4.16M | 2.08M | 2.08M | 2.84M | 3.38M |
| Common Stock | 122.51K | 54.42K | 48.23K | 47.73K | 47.65K | 47.63K |
| Additional Paid-In Capital | 38.43M | 33.13M | 30.95M | 28.15M | 26.85M | 26.55M |
| Retained Earnings | -36.93M | -33.25M | -29.51M | -23.96M | -17.57M | -19.75M |
| Comprehensive Income & Other | -28.73K | |||||
| Total Common Equity | 1.62M | -66.40K | 1.46M | 4.24M | 9.33M | 6.84M |
| Shareholders' Equity | 3.16M | -19.23K | 1.51M | 4.29M | 9.37M | 6.89M |
| Total Liabilities & Equity | 6.12M | 4.14M | 3.58M | 6.37M | 12.22M | 10.27M |
| Total Debt | 572.45K | 1.36M | 839.55K | 1.23M | 1.41M | 1.27M |
| Net Cash (Debt) | 3.97M | -332.65K | 944.46K | 2.86M | 7.40M | 2.08M |
| Net Cash Per Share | 0.56 | -0.07 | 0.20 | 0.60 | 0.78 | 0.22 |
| Filing Date Shares Outstanding | 12.77M | 10.44M | 4.82M | 4.77M | 4.76M | 4.73M |
| Total Common Shares Outstanding | 12.25M | 5.44M | 4.82M | 4.77M | 4.76M | 4.73M |
| Working Capital | 2.52M | -992.01K | 679.15K | 3.29M | 8.10M | 5.69M |
| Book Value Per Share | 0.13 | -0.01 | 0.30 | 0.89 | 1.96 | 1.45 |
| Tangible Book Value | 1.15M | -539.81K | 959.53K | 3.71M | 8.81M | 6.26M |
| Tangible Book Value Per Share | 0.09 | -0.10 | 0.20 | 0.78 | 1.85 | 1.32 |
| Machinery | 528.23K | 569.03K | 569.03K | 709.22K | 1.15M | 1.06M |
| Leasehold Improvements | 12.22K | 12.22K | 12.22K | 12.22K | 12.22K | 5.70K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -5.81M | -3.74M | -5.55M | -6.39M | 2.19M | 2.07M |
| Depreciation & Amortization | 78.94K | 85.76K | 138.53K | 167.29K | 288.69K | 123.66K |
| Other Amortization | 630.77K | 115.18K | 4.98K | 5.21K | 1.53K | |
| Loss (Gain) From Sale of Assets | 3.38K | |||||
| Asset Writedown & Restructuring Costs | 16.36K | 209.07K | 24.09K | |||
| Stock-Based Compensation | 938.12K | 516.18K | 2.18M | 1.30M | 176.08K | 182.68K |
| Other Operating Activities | 733.81K | 265.25K | -2.78K | -144.11K | ||
| Change in Accounts Receivable | -117.23K | -64.68K | -66.44K | 696.09K | 1.94M | -4.01M |
| Change in Inventory | -49.38K | -69.05K | 13.50K | 26.41K | 159.58K | -143.22K |
| Change in Accounts Payable | 470.17K | 496.24K | 12.03K | -104.00K | -248.49K | 363.21K |
| Change in Unearned Revenue | 73.67K | -63.77K | 265.58K | -61.35K | 163.52K | 82.24K |
| Change in Other Net Operating Assets | 263.88K | 537.99K | 395.02K | -331.33K | 1.11M | 400.14K |
| Operating Cash Flow | -2.79M | -1.92M | -2.60M | -4.48M | 5.80M | -1.07M |
| Capital Expenditures | -9.38K | -261.79K | -228.15K | |||
| Sale of Property, Plant & Equipment | 5.75K | |||||
| Sale (Purchase) of Intangibles | -12.85K | -34.38K | -206.51K | |||
| Investing Cash Flow | -12.85K | -43.76K | -462.55K | -228.15K | ||
| Long-Term Debt Issued | 988.47K | 183.17K | ||||
| Total Debt Issued | 1.17M | 988.47K | 183.17K | |||
| Long-Term Debt Repaid | -46.58K | -58.86K | -57.69K | |||
| Total Debt Repaid | -46.58K | -58.86K | -57.69K | |||
| Net Debt Issued (Repaid) | 1.17M | 988.47K | -46.58K | 124.30K | -57.69K | |
| Issuance of Common Stock | 4.75K | 4.75K | 583.00 | 12.00 | 24.00 | |
| Other Financing Activities | -846.43K | -23.86K | -148.39K | -11.71K | 10.00 | |
| Financing Cash Flow | 6.33M | 1.16M | 293.33K | -194.38K | 112.60K | 1.19M |
| Net Cash Flow | 3.52M | -758.02K | -2.31M | -4.72M | 5.45M | -113.72K |
| Free Cash Flow | -2.79M | -1.92M | -2.60M | -4.49M | 5.54M | -1.30M |
| Free Cash Flow Margin | -136.84% | -93.87% | -148.30% | -315.20% | 50.11% | -13.53% |
| Free Cash Flow Per Share | -0.39 | -0.39 | -0.54 | -0.94 | 0.58 | -0.14 |
| Levered Free Cash Flow | -805.68K | -634.03K | -924.16K | -2.43M | 4.02M | |
| Unlevered Free Cash Flow | -1.00M | -651.58K | -921.23K | -2.42M | 4.03M | |
| Change in Working Capital | 641.11K | 836.73K | 619.69K | 225.81K | 3.12M | -3.31M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Debt / Equity Ratio | 0.18 | -70.67 | 0.56 | 0.29 | 0.15 | 0.18 |
| Debt / EBITDA Ratio | 0.68 | 0.57 | ||||
| Debt / FCF Ratio | 0.26 | |||||
| Net Debt / Equity Ratio | -1.26 | -17.30 | -0.63 | -0.67 | -0.79 | -0.30 |
| Net Debt / EBITDA Ratio | 0.92 | -0.10 | 0.17 | 0.46 | -3.89 | -1.01 |
| Net Debt / FCF Ratio | 1.42 | -0.17 | 0.36 | 0.64 | -1.33 | 1.60 |
| Asset Turnover | 0.46 | 0.53 | 0.35 | 0.15 | 0.98 | |
| Inventory Turnover | 16.18 | 17.64 | 25.82 | 17.80 | 35.58 | |
| Quick Ratio | 1.90 | 0.50 | 1.42 | 4.11 | 5.87 | 3.36 |
| Current Ratio | 1.99 | 0.60 | 1.50 | 4.25 | 5.97 | 3.52 |
| Return on Equity (ROE) | -331.22% | -503.12% | -191.67% | -93.56% | 26.89% | |
| Return on Assets (ROA) | -62.37% | -53.92% | -71.10% | -42.79% | 9.33% | |
| Return on Capital Employed (ROCE) | -123.20% | -199.00% | -253.90% | -118.80% | 15.90% | 24.20% |
| Buyback Yield / Dilution | -47.91% | -2.70% | -0.66% | 49.73% | -0.26% | -100.78% |